NEW CLINCIAL DATA FOR THE CYPHER STENT TO BE PRESENTED AT SESSION
New clinical data for the Cypher Sirolimus-Eluting Stent in heart attacks and long lesions will be presented at the upcoming American College of Cardiology Annual Scientific Session, to be held in Atlanta, Ga.
More than 20 clinical studies examining cardiology, endovascular and cell therapy technologies will be presented at the session. Clinical findings will be presented at clinical trials sessions and in plenary and poster sessions throughout the four-day international cardiology meeting.
Among these presentations, clinical investigators will report on the first randomized trial clinical examining the use of the Cypher Sirolimus-eluting Coronary Stent in patients experiencing a heart attack, and two head-to-head randomized clinical trials comparing the Cypher Stent and the Taxus Stent in difficult-to-treat patients, one of which is also in patients experiencing a heart attack. Other studies will examine the company's carotid artery stenting system in patients at high-risk of stroke.